Insider at Ligand Pharmaceuticals Sells Shares Worth $1.1 Million

Andrew Reardon, CLO & Secretary at Ligand Pharmaceuticals (NASDAQ:LGND), sold 5,000 shares for approximately $1.1 million on June 1, 2026, following the exercise of stock options under an SEC Form 4 filing.

By Cory Renauer, The Motley Fool Sun, June 7, 2026 at 3:48 PM GMT+3 4 min read · Yahoo Finance · June 7, 2026, 12:48 UTC

Insider at Ligand Pharmaceuticals Sells Shares Worth $1.1 Million

Tickers: $LGND

Topics: executive sale SEC Form 4 filing stock options

Read the full article at Yahoo Finance

More World news

Aline Accounting Partners Secures $206 Million in Financing Led by Square Nine Capital PR Newswire · November 12, 2026, 18:00 UTC
Egan-Jones November 2026 Report Shows Soft CLO Issuance Amid Improving Credit Metrics PR Newswire · November 12, 2026, 18:00 UTC
Blackbaud Reports Third Quarter Revenue Growth and Strategic AI Integration Motley Fool · November 12, 2026, 17:53 UTC
Sprott Physical Copper Trust Reports Significant Increase in Q3 Net Income Seeking Alpha · November 12, 2026, 17:51 UTC
Federal Reserve to Designate October 2027 Meeting as Non-Voting Strategic Session CNBC · November 12, 2026, 17:48 UTC
Sprott Physical Platinum and Palladium Trust Reports Q3 Net Income Decline Seeking Alpha · November 12, 2026, 17:47 UTC
Nvidia CEO Jensen Huang Resigns Amidst Market Volatility and AI Sector Shifts Motley Fool · November 12, 2026, 17:45 UTC
Honda to Transition CR-V Lineup to All-Hybrid Powertrains by 2027 Seeking Alpha · November 12, 2026, 17:43 UTC
Sprott Physical Silver Trust USD Reports Q3 Net Income of $425.83 Million Seeking Alpha · November 12, 2026, 17:44 UTC
Nvidia CEO Jensen Huang Resigns Amid Allegations of Personal Misconduct and China Export Control Concerns The Verge · November 12, 2026, 17:44 UTC